ES2061816T3 - Utilizacion de 3,4-dihidro-2h-benzopiranos como agentes curativos contra trastornos funcionales obstructivos del pulmon. - Google Patents

Utilizacion de 3,4-dihidro-2h-benzopiranos como agentes curativos contra trastornos funcionales obstructivos del pulmon.

Info

Publication number
ES2061816T3
ES2061816T3 ES89112897T ES89112897T ES2061816T3 ES 2061816 T3 ES2061816 T3 ES 2061816T3 ES 89112897 T ES89112897 T ES 89112897T ES 89112897 T ES89112897 T ES 89112897T ES 2061816 T3 ES2061816 T3 ES 2061816T3
Authority
ES
Spain
Prior art keywords
alkil
dihydro
benzopyrans
lung
agents against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89112897T
Other languages
English (en)
Inventor
Heinrich Christian Dr Englert
Erik Dr Klaus
Dieter Dr Mania
Bernward Dr Scholkens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2061816T3 publication Critical patent/ES2061816T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE LA UTILIZACION DE 3,4 DIHIDRO-2H-BENZO(B)PIRANOS DE LA FORMULA I, EN LOS QUE HAY: R1 PARA H, OH(C1-C2)-ALCOXI, (C1-C2)-ALKIL O NR4R5, MIENTRAS QUE R4 Y R5 SON IGUALES O DIFERENTES Y ESTAN PARA H1(C1-C2) ALKIL O (C1-C3)ALKILCARBONIL. R2, R3 IGUAL O DIFERENTES Y ESTAN PARA ALKIL CON 1-4 ATOMOS. AR ESTA PARA UN SISTEMA AROMATICO HETEROAROMATICO, EL INSUSTITUIDO O SUSTITUIDO POR 1 A 3 RESTOS IGUALES O DIFERENTES (C1-C2)-ALKIL, HALOGENO, TRIFLUORMETILO, CN, NO2, CO-(C1-C2) ALKIL O SOM-(C1-C2)-ALKIL CON M=1 O 2; N ESTA PARA 1 O 2; X ESTA PARA UNA CADENA (CH2) QUE PUEDE SER INTERRUMPIDA POR UN HETEROATOMO O, S O NR6, PARA LO QUE R6 H O (C1-C4)-ALKIL SIGNIFICA R PARA LAS CIFRAS 2, 3, 4 O 5. PARA LA FABRICACION DE UN REMEDIO CONTRA OBSTRUCCIONES FUNCIONALES DE LOS PULMONES Y/O EN LAS VIAS URINARIAS DERIVADAS.
ES89112897T 1988-07-19 1989-07-14 Utilizacion de 3,4-dihidro-2h-benzopiranos como agentes curativos contra trastornos funcionales obstructivos del pulmon. Expired - Lifetime ES2061816T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3824446A DE3824446A1 (de) 1988-07-19 1988-07-19 Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege

Publications (1)

Publication Number Publication Date
ES2061816T3 true ES2061816T3 (es) 1994-12-16

Family

ID=6359009

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89112897T Expired - Lifetime ES2061816T3 (es) 1988-07-19 1989-07-14 Utilizacion de 3,4-dihidro-2h-benzopiranos como agentes curativos contra trastornos funcionales obstructivos del pulmon.

Country Status (18)

Country Link
EP (2) EP0351720B1 (es)
JP (1) JPH0273015A (es)
KR (1) KR900001367A (es)
AT (1) ATE110270T1 (es)
AU (1) AU621388B2 (es)
CA (1) CA1336891C (es)
CZ (1) CZ417091A3 (es)
DE (2) DE3824446A1 (es)
DK (1) DK171782B1 (es)
ES (1) ES2061816T3 (es)
FI (1) FI893460A7 (es)
HU (1) HU210149B (es)
IE (1) IE63872B1 (es)
IL (1) IL91015A (es)
NZ (1) NZ229961A (es)
PH (1) PH26696A (es)
PT (1) PT91197B (es)
ZA (1) ZA895459B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW244350B (es) * 1991-12-14 1995-04-01 Hoechst Ag
TW316850B (es) * 1992-02-28 1997-10-01 Takeda Pharm Industry Co Ltd
HUT72741A (en) * 1992-12-19 1996-05-28 Alkaloida Vegyeszeti Gyar Method for producing benzopyrane derivatives and pharmaceutical compositions containing them
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
WO2001047491A1 (en) * 1999-12-23 2001-07-05 Coifman Robert E Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer
KR100475147B1 (ko) * 2002-09-09 2005-03-10 정의상 알루미나 분진 중의 유해가스 제거를 위한 탈취제 조성물
DE60323533D1 (de) 2002-11-12 2008-10-23 Warner Lambert Co Methode zur stimulierung von haarwuchs auf der basis von benzopyranen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0107423B1 (en) * 1982-10-19 1986-07-23 Beecham Group Plc Novel chromans and chromenes
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
EP0277611B1 (de) * 1987-02-04 1993-06-16 Hoechst Aktiengesellschaft Alkylsubstituierte N-Benzopyranyllactame, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen

Also Published As

Publication number Publication date
CA1336891C (en) 1995-09-05
FI893460A7 (fi) 1990-01-20
JPH0273015A (ja) 1990-03-13
CZ417091A3 (en) 1993-02-17
AU3818989A (en) 1990-01-25
HUT55988A (en) 1991-07-29
HU210149B (en) 1995-02-28
FI893460A0 (fi) 1989-07-17
EP0560399A1 (de) 1993-09-15
EP0351720B1 (de) 1994-08-24
DK355489A (da) 1990-01-20
PT91197B (pt) 1995-07-18
KR900001367A (ko) 1990-02-27
EP0351720A2 (de) 1990-01-24
EP0351720A3 (de) 1992-01-02
NZ229961A (en) 1991-11-26
DE58908228D1 (de) 1994-09-29
PT91197A (pt) 1990-02-08
ATE110270T1 (de) 1994-09-15
ZA895459B (en) 1990-03-28
DE3824446A1 (de) 1990-01-25
IE892323L (en) 1990-01-19
PH26696A (en) 1992-09-15
AU621388B2 (en) 1992-03-12
DK355489D0 (da) 1989-07-18
DK171782B1 (da) 1997-05-26
IL91015A (en) 1994-11-28
IE63872B1 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
DK0453127T3 (da) Behandling af katarakt med 15-keto-prostaglandinforbindelser
CY1113610T1 (el) Συνθεσεις και μεθοδοι για αγωγη μιτοχονδριακων παθησεων
DE3382458D1 (de) Haarwuchsmittel.
ES2159043T3 (es) Derivado carboestirilico para el tratamiento de enfermedades oculares.
ES2061816T3 (es) Utilizacion de 3,4-dihidro-2h-benzopiranos como agentes curativos contra trastornos funcionales obstructivos del pulmon.
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
FI920430A0 (fi) Benzyloxifenylderivator.
DK0503887T3 (da) Fremme af sårheling med 15-ketoprostaglandinforbindelser
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
ES2089136T3 (es) Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas.
ATE132749T1 (de) Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
ES2058148T3 (es) N-benzopiranil-lactamas sustituidas con alquilo, procedimiento para su preparacion, su empleo, asi como preparados farmaceuticos a base de estos compuestos.
ES2033869T3 (es) Figura de muneco saltador de juguete.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE3377647D1 (de) 5-halovinyl-2'-deoxyuridine derivatives
ES2118818T3 (es) Tiazolin-2-onas aminoalquil-substituidas, su obtencion y empleo.
NO995539D0 (no) Anvendelse av hepariner med lav molekylvekt for prevensjon og terapi av cerebrale ödemer
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
ES2160093A1 (es) Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
ZA885875B (en) Chloroaniline derivatives
ES2089503T3 (es) Nuevos nitrilos del acido 1-aril-4-piperazinil-ciclohexanocarboxilico, su obtencion y empleo.
DE69001988D1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
MX9202880A (es) Derivados de cromano.
MX9204118A (es) 2-amino-1,3,4,-tiadiazoles aminoalquilsustituidos, su preparacion y su empleo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 351720

Country of ref document: ES